AN HAEi & ACARE EVENT
Madrid, Spain – March 2026

MAKE A DIFFERENCE

Welcome to the 2026 HAEi Global Angioedema Leadership Conference

Dear HAE Friends,

Building on the remarkable success of the 2024 HAEi Global Leadership Workshop and ACARE Global Angioedema Forum, we are delighted to invite you to participate in the 2026 Global Angioedema Leadership Conference – a joint HAEi and ACARE event.

The conference will take place from 26 to 29 March 2026 in Madrid, Spain, under the theme, “Make a Difference.” This event offers a unique platform for meaningful engagement with Key Patient Opinion Leaders from our 105 member countries, alongside key physicians, scientists, researchers, and industry representatives from the angioedema community.

The 2026 conference features 2 dynamic programs across 2 days:

For Patient Leaders: The program will focus on patient identification and diagnosis, advocacy training to optimize national impact, raising awareness through social media, medicine updates- both available and in development, and strategies for engaging with governments and health ministries.

For Angioedema Physicians, Scientists, and Researchers: The scientific program will include the latest insights on angioedema, differential diagnosis, and management strategies. It will also feature oral presentations selected from submitted abstracts, overview lectures, panel discussions, and poster sessions. The program will have a special focus on HAE.

The 2026 Global Angioedema Leadership Conference is an exceptional opportunity for the scientific, patient, and industry communities to come together, inspire each other, and strengthen collaborative partnerships.

We warmly invite you to join us and help navigate the future of angioedema care together.

We look forward to welcoming you to Madrid!

Registration

Registration for the 2026 HAEi Global Angioedema Leadership Conference will be on a first-come, first-served basis. We offer extremely attractive registration rates and conditions, so we advise you not to wait too long before registering. We expect to gather approximately 800 – 900 participants (including around 250 for the scientific program) from around the world, making the 2026 Global Angioedema Leadership Conference an event not to miss.

Anthony J. Castaldo
Chief Executive Officer, HAEi

Henrik Balle Boysen
President, HAEi

Prof. Dr. Markus Magerl
ACARE Steering Committee

To find out more about HAEi and our work, please visit our HAEi website at haei.org!

Wordly – Translation options

We will offer translation into 60+ languages during our 2026 Global Angioedema Leadership Conference. Languages currently supported by our translation partner “Wordly” include:

Afrikaans, Albanian, Arabic, Armenian, Bengali, Bulgarian, Cantonese, Catalan, Chinese (Simplified), Chinese (Traditional), Croatian, Czech, Danish, Dutch, English (AU), English (US), English (UK), Estonian, Finnish, French (CA), French (FR), Georgian, German, Greek, Gujarati, Hebrew, Hindi, Hungarian, Icelandic, Indonesian (Bahasa), Irish, Italian, Japanese, Kannada, Korean, Latvian, Lithuanian, Macedonian, Malay, Maltese, Norwegian, Persian, Polish, Portuguese (BR), Portuguese (PT), Punjabi, Romanian, Russian, Serbian, Slovak, Slovenian, Spanish (ES), Spanish (MX), Swahili, Swedish, Tagalog, Tamil, Thai, Turkish, Ukrainian, Urdu, Vietnamese, Welsh

Important information about HAE medication and traveling to and from Madrid, Spain

EXTREMELY IMPORTANT for all HAE patient participants:

  1. As a person with HAE, I confirm I will travel with a sufficient quantity of HAE medication to cover my needs while I am away from home.
  2. I confirm that I or my caregiver/travel companion is able to administer my prescribed therapy.

EXTREMELY IMPORTANT for all participants:

  1. I confirm that I have adequate travel insurance to travel to the 2026 Global Angioedema Leadership Conference – This is a mandatory requirement. I understand I will be traveling to a foreign country with a health care system that is likely to be very different than my home country. There is no guarantee that hospitals in Madrid, Spain, will have HAE medication available to treat an attack. I may also be required to pay for any emergency care or hospital visits.
  2. I understand that, as a participant in the 2026 Global Angioedema Leadership Conference, I am responsible for staying up to date on and complying with all travel regulations relating to COVID-19 and other mandatory vaccines. This includes requirements set by the airline, my country of origin, any transit countries, and my destination country.
  3. I consent to having my contact details and email address added as a subscriber to HAEi’s newsletter. This will allow me to receive relevant updates and information about HAE and HAEi. I understand I can unsubscribe from the newsletter at any time.

There will be no emergency care or HAE medication available at the Conference venue or accommodation hotel.

Neither HAEi nor any HAEi member organization, ACARE, nor the Global Asthma & Allergy Excellence Network can assume liability or be expected to provide medical care of any nature (HAE, Coronavirus, regular flu, etc.) if you experience problems during your stay in the Conference country or while traveling.

Read our Terms & Conditions here